The aspecific transport is gradient-dependent and may be significant in the use of high oral doses (0.5–1 mg), with a good efficacy also in persons with limited capacity for active absorption, such as in cases of pernicious anemia or gastric atrophy [ 70 , 71 ].
1
—
—